The patients were evaluated at three time points ( baseline , end of SLIT and 1 year after SLIT discontinuation ) regarding symptom scores including total nasal symptom score ( TNSS ) , sneezing , rhinorrhoea , nasal obstruction , nasal itching and total medication scores ( TMS ) and adverse reaction .